Document is current
Any future updates will be listed below
-
Authors
Andriana, Putri
Palani, Senthil
Liljenbäck, Heidi
Iqbal, Imran
Oikonen, Vesa
Virta, Jenni
Makrypidi, Konstantina
Rajander, Johan
Atencio Herre, Erika
Suni, Aino
Jalkanen, Sirpa
Knuuti, Juhani
Martinez-Pomares, Luisa
Pirmettis, Ioannis
Li, Xiang-Guo
Saraste, Antti
Roivainen, Anne https://orcid.org/0000-0002-4006-7977
-
Funding
Funding for this research was provided by:
Jane ja Aatos Erkon Säätiö
Sydäntutkimussäätiö
Academy of Finland (350117)
Sigrid Juséliuksen Säätiö
Orionin Tutkimussäätiö
Turun Yliopistosäätiö
- License Information
-
More Information
Article History
Received: 24 February 2025
Accepted: 6 May 2025
First Online: 4 June 2025
Declarations
:
: All animal experiments were approved by the national Project Authorization Board in Finland (license number ESAVI/43134/2019) and carried out in compliance with the EU Directive 2010/EU/63 on the protection of animals used for scientific purposes.
: Not applicable.
: Dr. Saraste received consultancy fees from AstraZeneca and Pfizer, and speaker fees from Abbott, AstraZeneca, Janssen, Novartis, and Pfizer (not related to the current study). Dr. Knuuti received consultancy fees from GE Healthcare and Synektik, and speaker fees from Bayer, Lundbeck, Boehringer-Ingelheim, Pfizer, and Siemens (outside of the submitted work). The remaining authors have no conflicts of interest to disclose.
